195 related articles for article (PubMed ID: 21998735)
1. Chronic effects of palmitate overload on nutrient-induced insulin secretion and autocrine signalling in pancreatic MIN6 beta cells.
Watson ML; Macrae K; Marley AE; Hundal HS
PLoS One; 2011; 6(10):e25975. PubMed ID: 21998735
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells.
Fontés G; Semache M; Hagman DK; Tremblay C; Shah R; Rhodes CJ; Rutter J; Poitout V
Diabetes; 2009 Sep; 58(9):2048-58. PubMed ID: 19502418
[TBL] [Abstract][Full Text] [Related]
3. Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate.
Sun Y; Ren M; Gao GQ; Gong B; Xin W; Guo H; Zhang XJ; Gao L; Zhao JJ
Acta Pharmacol Sin; 2008 Apr; 29(4):443-50. PubMed ID: 18358090
[TBL] [Abstract][Full Text] [Related]
4. Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.
Panse M; Gerst F; Kaiser G; Teutsch CA; Dölker R; Wagner R; Häring HU; Ullrich S
Cell Physiol Biochem; 2015; 35(4):1537-45. PubMed ID: 25792236
[TBL] [Abstract][Full Text] [Related]
5. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid-induced oxidation and triglyceride formation is higher in insulin-producing MIN6 cells exposed to oleate compared to palmitate.
Thörn K; Bergsten P
J Cell Biochem; 2010 Oct; 111(2):497-507. PubMed ID: 20524206
[TBL] [Abstract][Full Text] [Related]
7. Negative Effects of Cyclic Palmitate Treatment on Glucose Responsiveness and Insulin Production in Mouse Insulinoma Min6 Cells Are Reversible.
Nie Y; Li J; Jin Y; Nyomba BLG; Cattini PA; Vakili H
DNA Cell Biol; 2019 Apr; 38(4):395-403. PubMed ID: 30702352
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pancreatic β-cell Ca2+/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerance.
Dadi PK; Vierra NC; Ustione A; Piston DW; Colbran RJ; Jacobson DA
J Biol Chem; 2014 May; 289(18):12435-45. PubMed ID: 24627477
[TBL] [Abstract][Full Text] [Related]
9. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction.
Lovis P; Roggli E; Laybutt DR; Gattesco S; Yang JY; Widmann C; Abderrahmani A; Regazzi R
Diabetes; 2008 Oct; 57(10):2728-36. PubMed ID: 18633110
[TBL] [Abstract][Full Text] [Related]
10. Autocrine anti-apoptotic and proliferative effects of insulin in pancreatic beta-cells.
Muller D; Jones PM; Persaud SJ
FEBS Lett; 2006 Dec; 580(30):6977-80. PubMed ID: 17161395
[TBL] [Abstract][Full Text] [Related]
11. Growth receptor binding protein 10 inhibits glucose-stimulated insulin release from pancreatic β-cells associated with suppression of the insulin/insulin-like growth factor-1 signalling pathway.
Li L; Li X; Zhu Y; Zhang M; Yin D; Lu J; Liu F; Wang C; Jia W
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):841-7. PubMed ID: 23937793
[TBL] [Abstract][Full Text] [Related]
12. Palmitate and insulin counteract glucose-induced thioredoxin interacting protein (TXNIP) expression in insulin secreting cells via distinct mechanisms.
Panse M; Kluth O; Lorza-Gil E; Kaiser G; Mühlbauer E; Schürmann A; Häring HU; Ullrich S; Gerst F
PLoS One; 2018; 13(5):e0198016. PubMed ID: 29813102
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
14. High glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y(13) receptor.
Tan C; Voss U; Svensson S; Erlinge D; Olde B
Purinergic Signal; 2013 Mar; 9(1):67-79. PubMed ID: 22941026
[TBL] [Abstract][Full Text] [Related]
15. Effects of CaMKII-mediated phosphorylation of ryanodine receptor type 2 on islet calcium handling, insulin secretion, and glucose tolerance.
Dixit SS; Wang T; Manzano EJ; Yoo S; Lee J; Chiang DY; Ryan N; Respress JL; Yechoor VK; Wehrens XH
PLoS One; 2013; 8(3):e58655. PubMed ID: 23516528
[TBL] [Abstract][Full Text] [Related]
16. Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells.
Watson ML; Coghlan M; Hundal HS
Biochem J; 2009 Feb; 417(3):791-801. PubMed ID: 18922131
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
18. Blockage of ceramide metabolism exacerbates palmitate inhibition of pro-insulin gene expression in pancreatic beta-cells.
Guo J; Qian Y; Xi X; Hu X; Zhu J; Han X
Mol Cell Biochem; 2010 May; 338(1-2):283-90. PubMed ID: 20063116
[TBL] [Abstract][Full Text] [Related]
19. Curcumin attenuates palmitate-induced apoptosis in MIN6 pancreatic β-cells through PI3K/Akt/FoxO1 and mitochondrial survival pathways.
Hao F; Kang J; Cao Y; Fan S; Yang H; An Y; Pan Y; Tie L; Li X
Apoptosis; 2015 Nov; 20(11):1420-32. PubMed ID: 26330141
[TBL] [Abstract][Full Text] [Related]
20. Low-grade elevation of palmitate and lipopolysaccharide synergistically induced β-cell damage via inhibition of neutral ceramidase.
Xu YN; Wang Z; Zhang SK; Xu JR; Pan ZX; Wei X; Wen HH; Luo YS; Guo MJ; Zhu Q
Mol Cell Endocrinol; 2022 Jan; 539():111473. PubMed ID: 34610358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]